Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-γ receptor mutation

Clinical Infectious Diseases

Volumn 39, Issue 6, 2004, Pages 868-870

  Han, Jin Young ^a   Rosenzweig, Sergio D ^b   Church, Joseph A ^a   Holland, Steven M ^b   Ross, Lawrence A ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CLARITHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON RECEPTOR; ISONIAZID; KANAMYCIN; RIFABUTIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FAMILY STUDY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INFANT; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM KANSASII; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; PEDIGREE; RECEPTORS, INTERFERON;

EID: 4544334445     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423804     Document Type: Article

References (18)

1. Engbaek HC. Three cases in the same family of fatal infections with M. Avium. Acta Tuberc Scand 1964; 45:105-17.
2. Schonell ME, Crofton JW, Stuart AE, Wallace A. Disseminated Infection with Mycobacterium avium I: clinical features, treatment and pathology. Tubercle 1968; 49:12-30.
3. Levin M, Newport MJ, D'Souza S, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345:79-83.
4. de Jong R, Altare IA, Haagen DG, et al. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280:1435-8.
5. Casanova J-L, Jouanguy E, Lamhamedi S, et al. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346:581.
6. Altare F, Lammar D, Revy PE, et al. Inherited interleukin-12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 1998; 102:2035-40.
7. Dorman SE, Uzel G, Roesler J, et al. Viral infections in interferon gamma receptor deficiency. J Pediatr 1999; 135:640-3.
8. Fieschi C, Cananova J-L. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol 2003; 33:1461-4.
9. Cleary AM, Tu W, Enright A, et al. Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor BI deficiency. J Immunol 2003; 170:597-603.
10. Guide SV, Holland SM. Host susceptibility factors in mycobacterial infection. Infect Dis Clinics North America 2002; 16:163-86.
11. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Ann Review Immunol 2002; 20:581-620.
12. Villella A, Picard C, Jouanguy E, et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 2001; 107:e47.
13. Sasaki Y, Nomura A, Kusuhara K, et al. Genetic basis of patients with bacille Calmette - Guérin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis 2002; 185:706-9.
14. Jouanguy E, Lamhamedi-Cherradi S, Lammar D, et al. A human IFNg R1 small deletion hot spot associated with dominant susceptibility to mycobacterial infections. Nature Genetics 1999; 21:370-8.
15. McKusick VA, ed. Mendelian inheritance in man: catalogs of human genes and genetic disorders. 12th ed. Baltimore: Johns Hopkins University Press, 1998.
16. Fogun L. Atypical mycobacteria: their clinical, laboratory, and epidemologic significance. Medicine (Baltimore) 1970; 49:243-55.
17. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100:2658-64.
18. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22:329-60.